FDA Investigator Myla T Collins
Myla T Collins has inspections in 1 countries as of 23 Jun 2023. Myla T Collins has collaborated with a combined 1267 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
41
Last Inspection Date:
23 Jun 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Abby Lmozeke Baker,
Amanda B Athey,
Andrew Saunders,
Anna E Fain,
Ashley N Brooks,
Ashley N Jeans,
Barbara D Wright,
Barbara T Carmichael,
Brandon C Heitmeier,
Brentley S Collins,
Brian S Lynch,
Caitlin L Almonrode,
Carter,
Cherie T Parker,
Cheryl G Scott,
Cheryl L Watson,
Christopher J Adams,
Clendening,
Cody D Rickman,
Coral Del M Lopez,
Cynthia L Medlin,
Danielle M Maddox,
David R Heiar,
Donna D Gallien, MPH,
Dyanthony T Jenkins,
Elizabeth D Battles,
Elizabeth D Connell,
Elkins,
Emily E Smith,
Eric R Holm,
Fabian Nchaparro Rodriguez,
Ferrante,
Hultman,
Hung V Le,
Jason D Abel,
Jocelyn C Turner,
Johnathan M Crayton,
Juanelma H Palmer,
June P Page,
Karen Gale,
Karen Gale Sego,
Kenneth Merritt,
Kenneth R Merritt,
Kimberly A Dutzek,
Kimberly L Mcmillan,
Kip J Hanks,
Konsuela Y Glass,
Lacey J Chessor,
Laressa R Gray,
Laura L Staples,
Leslie F Sanders,
Lindsay H Bertling,
Llopis,
Lura D Baquero,
Lura D Kelly,
Margaret E Slimbach,
Marshall H Kinsey,
Mary A Millner,
Matthew R Mcnew,
Melanie L Drayton,
Mpris Inspector,
Natasha N Mccants,
Nikki S Bryant,
Oregan,
Patricia S Smith,
Sanders,
Shirhonda D Thorn,
Shondra N Gipson,
State Agency,
Stephanie A Cochran,
Steven D Dittert,
Teresa Y Bills,
Thomas B Smith,
Whitney M White,
Wilvor K Butler,
Zada L Giles
Myla T Collins's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2010 | FDA 483 | Diversified Diagnostic Products, Inc - Form 483, 2010-06-11 |
January, 2013 | FDA 483 | LifeSouth Community Blood Centers Inc - Form 483, 2013-01-31 |
January, 2013 | EIR | LifeSouth Community Blood Centers Inc - EIR, 2013-01-31 |
February, 2012 | FDA 483 | Permobil Inc - Form 483, 2012-02-16 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more